home / stock / mgtx / mgtx message board
Subject | By | Source | When |
---|---|---|---|
must see | stockguard | investorshub | 05/02/2023 11:41:04 AM |
$MGTX MomentumIts trading | mcp4 | investorshub | 04/25/2023 8:18:05 PM |
$MGTX must see | mcp4 | investorshub | 04/18/2023 7:07:33 PM |
znewcar1: MGTX 29% v7,7M c18.56 f44,3M H19.17 | znewcar1 | investorshangout | 10/18/2021 8:15:27 PM |
MeiraGTx (NASDAQ:MGTX) Given Buy Rating at Piper Jaffray Companies | stockguard | investorshub | 12/30/2019 9:54:37 PM |
Janssen Pharmaceuticals and MeiraGTx just entered into a | mcp4 | investorshub | 10/19/2018 5:17:08 PM |
Zacks Investment Research downgraded $MGTX from a hold | mcp4 | investorshub | 09/10/2018 1:07:16 PM |
Chardan Capital just rated $MGTX a Buy with | mcp4 | investorshub | 08/24/2018 5:44:35 PM |
Some recent analyst comments on $MGTX: | mcp4 | investorshub | 08/21/2018 1:38:10 PM |
FDA has granted orphan drug designation to MeiraGTx's | mcp4 | investorshub | 08/15/2018 6:32:59 PM |
European Medicines Agency's (EMA) Committee gave MieraGTx a | mcp4 | investorshub | 07/03/2018 7:17:44 PM |
News, Short Squeeze, Breakout and More Instantly...
MeiraGTx Holdings plc Company Name:
MGTX Stock Symbol:
NASDAQ Market:
- Positive data from the Phase 1 AQUAx study in radiation-induced xerostomia (RIX) presented in an oral session at the American Academy of Oral Medicine 2024 annual meeting (AAOM) April 17-20, 2024 - Received $50 million milestone following initiation of the extension study for the Ph...
LONDON and NEW YORK, April 18, 2024 (GLOBE NEWSWIRE) -- MeiraGTx Holdings plc (NASDAQ:MGTX), a vertically integrated, clinical stage gene the...
LONDON and NEW YORK, April 18, 2024 (GLOBE NEWSWIRE) -- MeiraGTx Holdings plc (Nasdaq: MGTX), a vertically integrated, clinical stage gene therapy company, today announced the Company gave an oral presentation at the American Academy of Oral Medicine Annual Conference, being held f...